|
 |
European Biopharmaceutical Review
|
'Robot' is a Czech word meaning worker, from the play RUR: Rossums' Universal Robots by the Bohemian writer Karel Capek. The robot has since become an inspiration for science fiction writers and for engineers. Of course the science fiction vision of a robot is a mechanical man, but the reality we see in industry is simply a robotic arm. This is a versatile programmable manipulator, an integration of mechanics, electronics and software, designed interdependently to produce the mechanical equivalent of the computer - an undedicated machine unable to do anything until we program it.
In the pharmaceutical lab it is even less than that definition; the term 'robot' being applied to programmable liquid handlers. Drug development requires the screening of hundreds or thousands of samples and it is in this field that the robot arm is a vital tool. Such an automated screening system is called a 'high-throughput screening' (HTS) system.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
5 |
| | | | | |
|
|
 |
Industry Events |
 |
P-MEC Europe
5-7 October 2010, Paris, France
Hosted alongside CPhI, ICSE and BioPh, P-MEC (The Pharmaceutical Machinery and Equipment Convention) was first held in Madrid in 2005 and has since rapidly grown into a must-attend event for both sellers and buyers of pharmaceutical processing and manufacturing equipment. Now covering every aspect of pharma and biotech equipment, laboratory and analytical techniques to track & trace technologies, P-MEC Europe 2010 offers a perfect synergy between its sister events ICSE (The International Contract Services Expo) and BioPh Europe (bio solutions for pharma).
More info >> |
|
 |
News and Press Releases |
 |
Glycotope GMBH
Berlin, Germany – August 4, 2010
Glycotope GmbH, a leading glycobiology company, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX (GT-MAB 5.2-GEX) for the treatment of various solid cancers.
More info >> |
|
  |
